Table 1.
Clinical Variables | TCs | χ2 | p Value | |
---|---|---|---|---|
Low n (%) | High n (%) | |||
Gender | ||||
Male | 27 (60.0) | 18 (40.0) | 0.000 | 1.000 |
Female | 27 (60.0) | 18 (40.0) | ||
Age | ||||
<60 | 16 (55.2) | 13 (44.8) | 0.415 | 0.519 |
≥60 | 38 (62.3) | 23 (37.7) | ||
Smoking | ||||
No | 40 (60.6) | 26 (39.4) | 0.038 | 0.846 |
Yes | 14 (58.3) | 10 (41.7) | ||
T stage | ||||
I–II | 34 (60.7) | 22 (39.3) | 0.032 | 0.859 |
III–IV | 20 (58.8) | 14 (41.2) | ||
Lymph node metastasis | ||||
No | 33 (70.2) | 14 (29.8) | 4.275 | 0.039* |
Yes | 21 (48.8) | 22 (51.2) | ||
Differentiation | ||||
Well | 10 (62.5) | 6 (37.5) | 0.051 | 0.822 |
Moderate/poor | 44 (59.5) | 30 (40.5) | ||
DOI | ||||
<5 mm | 24 (64.9) | 13 (35.1) | 0.620 | 0.431 |
≥5 mm | 30 (56.6) | 23 (43.4) | ||
WPOI | ||||
I–III | 32 (72.7) | 12 (27.3) | 5.810 | 0.016 * |
IV–V | 22 (47.8) | 24 (52.2) |
DOI, depth of invasion; WPOI, worst pattern of invasion, χ2, Pearson’s chi-squared test. * represents that differences were considered statistically significant with p < 0.05.